KRAS and neoplasm: At the time of diagnosis, the proportion of patients with pleural metastases, as either the only metastatic site or concurrent with other metastatic sites, was higher for patients with KRAS wt tumours (13.1%) than patients with KRAS mut tumours (6.5%, p < 0.001).